Compound Overview
Class of Compound:
Peptide
Mechanism of Action:
As an analogue of growth hormone-releasing hormone, tesamorelin binds with the growth hormone-releasing hormone receptors of the anterior pituitary gland, thus stimulating the secretion of growth hormone.
Notable Studies:
Also Known As:
Egrifta, Tesamorelin Acetate, LGW5H38VE3, TH9507, UNII-LGW5H38VE3
Research Applications:
- Fat reduction
- Peripheral nerve health
- Cognitive health
Risks:
- Injection site pain
- FDA approval limited to HIV patients
- Prohibited by WADA
Chemical Structure


Reviews
Clear filtersThere are no reviews yet.